171 related articles for article (PubMed ID: 17382246)
1. Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.
She K; Gilman AL; Aslanian S; Shimizu H; Krailo M; Chen Z; Reid GS; Wall D; Goldman F; Schultz KR
Biol Blood Marrow Transplant; 2007 Apr; 13(4):386-97. PubMed ID: 17382246
[TBL] [Abstract][Full Text] [Related]
2. Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease.
Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D
Transplantation; 2008 Jun; 85(12):1826-32. PubMed ID: 18580477
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A
Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300
[TBL] [Abstract][Full Text] [Related]
4. Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis.
French LE; Alcindor T; Shapiro M; McGinnis KS; Margolis DJ; Porter D; Leonard DG; Rook AH; Foss F
Bone Marrow Transplant; 2002 Oct; 30(8):509-15. PubMed ID: 12379890
[TBL] [Abstract][Full Text] [Related]
5. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
[TBL] [Abstract][Full Text] [Related]
6. Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease.
Greinix HT; Pohlreich D; Kouba M; Körmöczi U; Lohmann I; Feldmann K; Zielinski C; Pickl WF
Biol Blood Marrow Transplant; 2008 Feb; 14(2):208-19. PubMed ID: 18215781
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of rituximab in chronic graft-versus-host disease.
Bates JS; Engemann AM; Hammond JM
Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
[TBL] [Abstract][Full Text] [Related]
8. Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB).
Arora M; Nagaraj S; Wagner JE; Barker JN; Brunstein CG; Burns LJ; Defor TE; McMillan ML; Miller JS; Weisdorf DJ
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1145-52. PubMed ID: 17889350
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. Immune modulation and chronic graft-versus-host disease.
Soiffer R
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S66-S69. PubMed ID: 18724307
[TBL] [Abstract][Full Text] [Related]
12. Altered homeostasis of CD4(+) memory T cells in allogeneic hematopoietic stem cell transplant recipients: chronic graft-versus-host disease enhances T cell differentiation and exhausts central memory T cell pool.
Fukunaga A; Ishikawa T; Kishihata M; Shindo T; Hori T; Uchiyama T
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1176-84. PubMed ID: 17889354
[TBL] [Abstract][Full Text] [Related]
13. Circulating endothelial progenitor cells decreased in patients with sclerodermatous chronic graft-versus-host disease.
Shimura K; Ashihara E; Shimazaki C; Matsunaga S; Taniguchi K; Uchiyama H; Matsumoto Y; Kimura S; Matsubara H; Taniwaki M; Maekawa T
Biol Blood Marrow Transplant; 2008 Apr; 14(4):426-37. PubMed ID: 18342785
[TBL] [Abstract][Full Text] [Related]
14. Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9.
Elmaagacli AH; Koldehoff M; Beelen DW
Bone Marrow Transplant; 2009 Sep; 44(5):295-302. PubMed ID: 19252531
[TBL] [Abstract][Full Text] [Related]
15. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
[TBL] [Abstract][Full Text] [Related]
16. B-cell involvement in chronic graft-versus-host disease.
Kapur R; Ebeling S; Hagenbeek A
Haematologica; 2008 Nov; 93(11):1702-11. PubMed ID: 18728020
[TBL] [Abstract][Full Text] [Related]
17. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
18. Acute autoimmune hemolytic anemia following unrelated cord blood transplantation as an early manifestation of chronic graft-versus-host disease.
Sevilla J; González-Vicent M; Madero L; Díaz MA
Bone Marrow Transplant; 2001 Jul; 28(1):89-92. PubMed ID: 11498750
[TBL] [Abstract][Full Text] [Related]
19. Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients.
Rudnicka W; Burakowski T; Warnawin E; Jastrzebska M; Bik M; Kontny E; Chorazy-Massalska M; Radzikowska A; Buler M; Maldyk P; Maslinski W
Eur J Immunol; 2009 May; 39(5):1211-20. PubMed ID: 19384869
[TBL] [Abstract][Full Text] [Related]
20. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
